HB 1158

  • Indiana House Bill
  • 2023 Regular Session
  • Introduced in House
  • House
  • Senate
  • Governor

Breakthrough therapies.

Abstract

Provides that a drug, biological product, or medical device that has been designated as a breakthrough therapy under federal law may be made available to a qualified patient and offered by a physician as a part of the patient's medical treatment. Specifies that a civil or criminal cause of action is not created against a manufacturer or health care provider for any harm to a qualified patient resulting from use of an investigational drug, biological product, or device.

Bill Sponsors (3)

Votes


No votes to display

Actions


Feb 13, 2023

House

Representatives Lucas and Miller K added as coauthors

Jan 10, 2023

House

Authored by Representative Moed

House

First reading: referred to Committee on Public Health

  • Reading-1
  • Referral-Committee
public health

Bill Text

Bill Text Versions Format
Introduced House Bill (H) PDF

Related Documents

Document Format
Fiscal Note: HB1158.01.INTR.FN001 PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Indiana General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.